- Q1 2024 AIM ImmunoTech Inc Earnings Call TranscriptMay 16, 2024$0.39 (-2.40%)Earnings
- Q4 2023 AIM ImmunoTech Inc Earnings Call TranscriptApr 02, 2024$0.45 (-8.18%)Earnings
- AIM ImmunoTech Inc at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Q2 2023 AIM ImmunoTech Inc Earnings Call TranscriptAug 15, 2023$0.6425 (-6.34%)Earnings
- AIM ImmunoTech Inc Investor Summer Spotlight Series TranscriptJul 12, 2023
- Q1 2023 AIM ImmunoTech Inc Earnings Call TranscriptMay 16, 2023$0.42495 (-0.01%)Earnings
- Q4 2022 AIM ImmunoTech Inc Earnings Call TranscriptApr 03, 2023$0.42 (-2.33%)Earnings
- AIM ImmunoTech Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- AIM ImmunoTech Inc at JTC Team Top Picks Virtual Investor Conference TranscriptJan 26, 2022
- AIM ImmunoTech Inc at SNN Network Virtual Conference TranscriptAug 03, 2020
- AIM ImmunoTech on Commercial Launch in Argentina for Chronic Fatigue and COVID-19 Clinical Trials- Corporate Analyst Meeting TranscriptJul 31, 2020
- CEO Roadshow Interview: Thomas Equels, CEO of AIM Immunotech Corporate Analyst Meeting TranscriptJun 24, 2020
- AIM ImmunoTech greenlit to import chronic fatigue syndrome drug into Argentina Corporate Analyst Meeting TranscriptJun 22, 2020
- AIM ImmunoTech Inc To Describe Their Approach and Progress with Ampligen to Combat COVID-19 TranscriptMay 28, 2020
- AIM ImmunoTech Inc at SNN Planet MicroCap Showcase TranscriptApr 22, 2020
AIM ImmunoTech Inc To Describe Their Approach and Progress with Ampligen to Combat COVID-19 Transcript
This is Robert Kraft and I'm your host for SNN Network. And joining me right now is Tom Equels. He's the President and CEO of AIM ImmunoTech. It's a publicly traded company. The symbol is AIM on the NYSE American. Tom, welcome back. Good to see you. How's everyone holding up?
Well, Robert, it's a pleasure to be here again. And we're doing really well in Ocala. That's where our headquarters is. And Ocala is a city. The metropolitan area is about 300,000, not a big city, but we have a remarkably low infection rate. There's only been about 200 cases so far during this entire pandemic, which is a very, very small percentage of the population. So we're grateful for that.
How are you and your family doing?
Our family is doing well. We're on lockdown, following all the guidelines and safety ordinances here in Los Angeles, and it's starting to slowly open up. I'm
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)